Novartis sets aside $700M in kickback case

pills

Swiss pharmaceutical drug maker Novartis announced it has set aside $700 million for a potential settlement in a long-running lawsuit over allegations that the company paid hundreds of millions of dollars in kickbacks to doctors to induce them into prescribing drugs to patients to boost their sales.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.